<DOC>
	<DOC>NCT01871077</DOC>
	<brief_summary>The purpose of this study is to evaluate safety and tolerability of the ophthalmic solution PRO-156 over the ocular surface of ophthalmologically healthy volunteers</brief_summary>
	<brief_title>Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers.</brief_title>
	<detailed_description>A phase I, open label and unicentric clinical trial to evaluate the safety and tolerability of the ophthalmic solution PRO-143 over the ocular surface of ophthalmologically healthy volunteers.</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Healthy male and female. Age between 18 and 40 years old at screening visit. Signed informed consent Patient with one blind eye. Any ocular or systemic condition. Visual acuity of 20/100 in any eye. Use of ocular or systemics medications. Contraindications or sensitivity to any component of the study treatment. Contact lens users. Ocular surgery within the past 3 months.. Pregnant, nursing or childbearing potential women who were not using effective contraception. Participation in any studies of investigational drugs within 90 days previous to the inclusion.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>